Philips and Cortechs.ai extend partnership to advance quantitative neuroimaging and strengthen Philips’ leadership in precision diagnostics in neurology
PHGNovember 19, 2025
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced an extended partnership with Cortechs.ai, a pioneer in quantitative neuroimaging solutions. Together, the companies will integrate Cortechs.ai’s advanced AI-enabled neuroimaging analytics directly into Philips’ MR systems [1], empowering clinicians with faster, more objective, and reproducible insights into brain health. The collaboration strengthens Philips’ leadership in precision neuro diagnostics, combining Philips’ next-generation MR technologies with Cortechs.ai’s AI-driven quantitative neuro imaging post processing software [1] to transform how neurological diseases are detected, monitored, and managed.
Combining complementary expertise for smarter brain imaging
Up to 25% [2] of all MR procedures are brain scans, and radiology departments face growing demand amid increasing staff shortages. At the same time, the number of patients with neur
Philips and Masimo announce innovation partnership to advance access to patient monitoring measurement technologies
PHG(NYSE:PHG) September 11, 2025
SPS Expands Philips SpeechLive with Ambient Medical AI Documentation, Powered by Corti
PHG(NYSE:PHG) VIENNA, Austria and COPENHAGEN, Denmark, Sept. 3, 2025 /PRNewswire/ -- Speech Processing Solutions (SPS), the global leader behind Philips SpeechLive, today announced a strategic partnership with Corti, the specialized AI infrastructure company for healthcare, to introduce ambient...
Philips launches Transcend Plus for EPIQ CVx and Affiniti CVx, delivering breakthrough image quality and FDA-cleared AI enhancements in cardiovascular ultrasound
PHGAugust 27, 2025
Philips Norelco launches Head Shaver Pro series, featuring elevated comfort and precision
PHGThe No. 1 electric shave brand* brings its unmatched blade technology to a new grooming category, helping deliver a smoother, more personalized headshave experience CAMBRIDGE, Mass., Aug. 25, 2025 /PRNewswire/ -- Today Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health...
Philips Announces Plan for More Than USD 150 Million of New Investment in Manufacturing and R&D in the U.S. to Expand Production of AI-powered Health Technology Innovations
PHGCAMBRIDGE, Mass.--(BUSINESS WIRE)--Philips, a global leader in health technology, today announced a plan for new investments of more than USD 150 million in U.S. manufacturing and research and development (R&D). As part of today’s announcement, Philips unveiled the expansion of its Reedsville, PA, manufacturing facility, which produces AI-enabled ultrasound systems for hospitals across the U.S. These investments come on top of Philips’ annual USD 900 million R&D investment in the U.S. a
Philips Announces 2024 Dividend Exchange Ratio Of One New Common Share For Every 23.6353 Existing Common Shares
PHGRoyal Philips Announced That It Will Repurchase Up To 6M Shares To Cover Certain Of Its Obligations Arising From Its Long-term Incentive Plans Representing An Amount Of Up To Approximately EUR 125M
PHGRoyal Philips And March Of Dimes Announced A Collaboration Aimed At Improving Maternal Health Education Through The Philips Avent Pregnancy+ App
PHGPhilips Launches RADIQAL Trial To Generate Evidence For Ultra-Low X-Ray Dose Technology For Coronary Procedures
PHGPhilips Launches 3D Heart Imaging Catheter In Europe to Boost Precision, Cut Anesthesia Use
PHGRoyal Philips Prices Offering Of EUR 500M Fixed Rate Notes Due 2030 And EUR 500M Fixed Rate Notes Due 2035 Under EMTN Program
PHGLower Demand In China Disrupts Philips Q1 Sales, Cuts 2025 Profitability Target On Potential Tariff Impact
PHGPhilips topped Q1 profit estimates with €0.25 EPS, cut its 2025 margin outlook due to tariffs, and reported €1.09 billion cash outflow tied to U.S. settlements.
Koninklijke Philips Holds 2025 Sales Growth Outlook At 1–3%; Trims Adjusted EBITA Margin To 10.8%-11.3%, Down 100 Bps From Prior On €250–300M Tariff Hit
PHGKoninklijke Philips Comparable Sales Fell 2% YoY, With China Down Double Digits; Personal Health Rose 1%, But Diagnosis & Treatment Dropped 4%
PHGKoninklijke Philips Q1 Adj. EPS $0.26 Beats $0.20 Estimate, Sales $4.31B Beat $4.10B Estimate
PHGPhilips And Mass General Brigham Collaborate To Unify Medical Data With AI For Smarter Clinical Decisions
PHGUBS Upgrades Koninklijke Philips to Buy
PHGPhilips Stock Falls As China Weakness Drags Q4 Earnings, 2025 Outlook
PHGPhilips Q4 earnings missed estimates as sales hit €5.04 billion. The company raised its 2023-2025 savings target to €2.5 billion and expects 2025 sales growth of 1%-3%.
Koninklijke Philips For 2025 Expects 1%-3% Comparable Sales Growth, Adjusted EBITA Margin Of 11.8%-12.3%; Sees Free Cash Flow Of EUR 0.4B-EUR 0.6B
PHGKoninklijke Philips Q4 Comparable Order Intake Up 2%, Driven By North America And Growth Markets; Comparable Sales Rise 1%, With 5% Growth Outside China Offset By A Double-Digit Decline
PHGKoninklijke Philips Q4 2024 Adj. EPS €0.51 Misses €0.57 Estimate, Sales €5.044B Miss €5.100B Estimate
PHGPhilips Enrolls First U.S. Patient In Clinical Trial For Single-Device Laser System To Treat Peripheral Artery Disease, Achieving Milestone In PAD Treatment Innovation
PHGRoyal Philips Announced The Successful Nationwide Rollout Of Its Ambulatory Cardiac Monitoring Service In Spain Using Its Unique Wearable ePatch Paired With Its AI-driven Cardiologs Analytics Platform
PHGPhilips Presents Study Results At Heart Rhythm Annual Meeting Showcasing Benefits Of Its AI-Powered Cardiac Monitoring Solution
PHGResMed's Q3 Earnings Short Of Expectations, Profit Margins Contract
PHG